Pediatrics

How adolescents with inflammatory bowel disease treated with immunosuppressive drugs respond to COVID-19 vaccination

In a letter published in Gut, Dr. Kevan Jacobson, Dr. Pascal Lavoie and collaborators from the University of British Columbia report modestly lower antibody levels in adolescents, aged 12 to 17 years, with inflammatory bowel disease (IBD) who are on the anti-TNF-a anti-inflammatory therapy infliximab in combination with other immunosuppressive drugs or given as [...]

2021-11-30T12:53:48-05:00November 30, 2021|Pediatrics|

Low transmission of SARS-CoV-2 observed in kindergarten to grade 12 schools in British Columbia

Drs. Pascal Lavoie and Louise Mâsse from the University of British Columbia and their team have released new findings from their CITF-funded study of SARS-CoV-2 transmission in Vancouver schools. In a pre-print, not-yet peer reviewed, their results suggest that despite the presence of variants of concern last spring, there was low transmission of SARS-CoV-2 [...]

2021-11-30T12:53:47-05:00November 30, 2021|Pediatrics|

COVID Infections in children and teens continue to rise, study finds

CITF-funded researcher Dr. Kate Zinszer, from the Université de Montréal, and her EnCORE study team have released additional preliminary, non-peer reviewed results indicating a marked increase in the number of Montreal youth aged 2 to 17 with antibodies due to a SARS-CoV-2 infection in recent months. They found that 9.7% of participants had antibodies [...]

2021-11-16T15:56:34-05:00November 12, 2021|Pediatrics|

Increasing infection rates and emotional distress among children in Montreal

Dr. Kate Zinszer (Université de Montréal) and her EnCORE study team have released preliminary results based on data collected from an online questionnaire that parents filled out including updates on children’s behaviour and emotional health, as well as many parental concerns. Most parents believed that vaccines will help stop the spread of COVID-19 and [...]

2021-06-08T17:36:27-04:00June 8, 2021|Pediatrics|

Preliminary results suggest nearly 6% of Montreal children tested from October to April had antibodies to SARS-CoV-2

Preliminary results from a study underway in Montreal shed important light on the extent to which 2 to 17 years-old have had COVID-19 between last October 2020 and this April 2021. As an overall average, 5.8% of participating children were found to have antibodies to SARS-CoV-2, the virus that causes COVID-19.

2021-05-17T21:43:27-04:00May 18, 2021|Media Releases, Pediatrics|

Montreal pediatric study releases preliminary results: infection rates increasing among children, parents eager to get their children vaccinated

Dr. Kate Zinszer, from the Université de Montréal, and her EnCORE study team have released interim non-peer reviewed results suggesting a marked increase in seroprevalence among Montreal children aged 2-17 years-old in recent months. They found that 3.3% of participants had antibodies to SARS-CoV-2 in October-November 2020, whereas 8.9% had antibodies between February-April 2021, [...]

2021-05-18T15:16:51-04:00May 18, 2021|Pediatrics|

Study finds few youths on the West Island and in the Plateau have had diagnosed cases of COVID-19, but mental health is an issue

Preliminary results from a study underway in Montreal suggest 41% of 1,000 children surveyed so far, largely based on participants from the West Island and the Plateau, have gone to get tested to see if they were infected at the time with SARS-CoV-2, the virus that causes COVID-19. Of those, 99% tested negative. In this surveyed group, children from 10 households also had family members test positive for SARS-CoV-2, yet only one child from these households tested positive.

2021-02-25T17:15:52-05:00December 14, 2020|Media Releases, Pediatrics|
Go to Top